Last reviewed · How we verify
NCT03500536
Understanding the Efficacy of Mobile Apps as Intervention for Depression in Adults When Deployed as Part of Primary Care.
NA trial testing IntelliCare in Depression in 146 participants. Completed in 4 April 2019.
4 April 2019
Quick facts
| Lead sponsor | Actualize Therapy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 146 |
| Start date | 18 July 2018 |
| Primary completion | 4 April 2019 |
| Estimated completion | 4 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- IntelliCare
Conditions studied
- Depression — all drugs for Depression →
- Anxiety — all drugs for Anxiety →
- Primary Health Care — all drugs for Primary Health Care →
Sponsor
Actualize Therapy
Who can join
18 and older, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients: A Randomized Clinical Trial.
Graham AK, Greene CJ, Kwasny MJ, Kaiser SM, et al · · 2020 · cited 117× · PMID 32432695 · DOI 10.1001/jamapsychiatry.2020.1011
Verify or expand the search:
- PubMed search for NCT03500536
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of IntelliCare
Trials testing the same drug.
- NCT05525689 — Evaluating Technology Enabled Services in Perinatal Depression · NA · completed
- NCT05274620 — Integrating a Suite of Mental Health Apps for Depression in a Healthcare Setting · NA · completed
- NCT04583891 — Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design · NA · completed
- NCT04499729 — Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation · NA · terminated
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03500536 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Actualize Therapy
- Last refreshed: 30 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03500536.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing